These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 5934253)

  • 21. [Formulation of sustained release tablets. I. Inert matrices].
    Salomen JL; Doelker E
    Pharm Acta Helv; 1980; 55(7):174-82. PubMed ID: 7413682
    [No Abstract]   [Full Text] [Related]  

  • 22. [Formulation of sustained-release tablets. II. Hydrophilic matrices].
    Buri P; Doelker E
    Pharm Acta Helv; 1980; 55(7-8):189-97. PubMed ID: 7433467
    [No Abstract]   [Full Text] [Related]  

  • 23. Indomethacin release from ion-exchange microspheres: impregnation with alginate reduces release rate.
    Chretien C; Boudy V; Allain P; Chaumeil JC
    J Control Release; 2004 May; 96(3):369-78. PubMed ID: 15120894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Manufacture and in vitro characterization of a new fluid theophylline sustained-release form. Sachets with microcapsules for administration in a drinkable sustained-release suspension].
    Weiss G; Klemm FH; Fuchs WS; Stanislaus F; Zema M; Calanchi M
    Arzneimittelforschung; 1998 May; 48(5A):604-12. PubMed ID: 9676353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Preparation and in vitro release of ginkgo biloba extract sustained-release tablets].
    Cui Q; Zhu Y; Cui J
    Zhongguo Zhong Yao Za Zhi; 2009 Aug; 34(15):1910-3. PubMed ID: 19894532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of nano drug carriers towards optimum release rate.
    Ng EY; Ng WK
    J Med Eng Technol; 2007; 31(4):243-52. PubMed ID: 17566928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formula optimization based on neural networksin sustained release tablets.
    Wei X; Liang W
    Pharmazie; 2003 Jul; 58(7):521-2. PubMed ID: 12889541
    [No Abstract]   [Full Text] [Related]  

  • 28. Novel sustained release, swellable and bioadhesive gastroretentive drug delivery system for ofloxacin.
    Chavanpatil MD; Jain P; Chaudhari S; Shear R; Vavia PR
    Int J Pharm; 2006 Jun; 316(1-2):86-92. PubMed ID: 16567072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The preparation and the in vitro release of OANO-1 microspheres].
    Yang F; Bi GW; Long XY; Yu ZM; Yang WS; Feng LP
    Zhongguo Zhong Yao Za Zhi; 2005 Jul; 30(13):992-4. PubMed ID: 16161426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extrudable core system: development of a single-layer osmotic controlled-release tablet.
    Waterman KC; MacDonald BC; Roy MC
    J Control Release; 2009 Mar; 134(3):201-6. PubMed ID: 19100796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of shape factor on the release rate of drugs from lipid matrices.
    Ozdemir N; Karataş A
    Acta Pol Pharm; 1997; 54(5):353-6. PubMed ID: 9584692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic efficacy of sustained drug release from chitosan gel on local inflammation.
    Kofuji K; Akamine H; Qian CJ; Watanabe K; Togan Y; Nishimura M; Sugiyama I; Murata Y; Kawashima S
    Int J Pharm; 2004 Mar; 272(1-2):65-78. PubMed ID: 15019070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stability study of ambroxol hydrochloride sustained release pellets coated with acrylic polymer.
    Kibria G; Islam KM; Jalil RU
    Pak J Pharm Sci; 2009 Jan; 22(1):36-43. PubMed ID: 19168418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of drug release kinetics of shellac-based matrix tablets by in-situ polymerization through annealing process.
    Limmatvapirat S; Limmatvapirat C; Puttipipatkhachorn S; Nunthanid J; Luangtana-anan M; Sriamornsak P
    Eur J Pharm Biopharm; 2008 Aug; 69(3):1004-13. PubMed ID: 18362064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug delivery via ion exchange across a fiber membrane.
    Jenke DR
    Pharm Res; 1989 Jan; 6(1):96-9. PubMed ID: 2717525
    [No Abstract]   [Full Text] [Related]  

  • 37. [Preparation of Delagil syrup using dextran-based ion exchangers].
    Halmosi L; Tóth Z
    Acta Pharm Hung; 1975 Nov; 45(6):245-9. PubMed ID: 1211178
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute toxicity as a method of assessing sustained release preparations.
    SHENOY KG; GRICE HC; CAMPBELL JA
    Toxicol Appl Pharmacol; 1960 Jan; 2():100-10. PubMed ID: 14445819
    [No Abstract]   [Full Text] [Related]  

  • 39. [Current theoretical concepts for developing biologically optimal retard preparation].
    Békefi E; Bozzay J; Csürös Z; Dávid A; Soós R
    Acta Pharm Hung; 1975 Nov; 45(6):225-36. PubMed ID: 1211177
    [No Abstract]   [Full Text] [Related]  

  • 40. Oral sustained-release medications.
    KWIT NT
    Am J Nurs; 1963 May; 63():74-6. PubMed ID: 13927759
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.